Literature DB >> 7212609

Nasopharyngeal carcinoma: epidemiology, histopathology and aetiology.

K Shanmugaratnam.   

Abstract

The highest incidence of nasopharyngeal carcinoma (around 20 per 100,000 per year) is found in Chinese populations in many countries. Elevated rates (5--15) are found in Eskimos, and in several racial groups in South-East Asia. The incidence rates in Malta and in some parts of Northern Africa are also moderately elevated. The incidence rates are low (less than 1) in virtually all other parts of the world. In Singapore, the incidence rates are high in Chinese (18.4), intermediate in Malays (4.7) and low in Indians (less than 1). Among the various Chinese communities, the incidence rates in Cantonese (29.1 and 11.0 for males and females respectively) are significantly higher than those in Hokkiens (14.1 and 4.7), Teochews (18.3 and 6.2), Hainanese (14.2 and 3.3) and Hakkas (12.6 and 4.8). The tumour has a male preponderance (2--3 times) and a peak incidence in the 5th and 6th decades. Nasopharyngeal carcinoma (NPC) is the commonest form of nasopharyngeal cancer in man. All histological types of NPC have consistently shown ultrastructural evidence of squamous differentiation and may be regarded as variants of a homogeneous group of tumours. The development of the neoplasm is attributable to the action of environmental factors in genetically susceptible persons. There is growing evidence that nitrosamine compounds and the Epstein-Barr virus may be involved in the aetiology of this neoplasm.

Entities:  

Mesh:

Year:  1980        PMID: 7212609

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  9 in total

1.  Identification of candidate molecular markers of nasopharyngeal carcinoma by tissue microarray and in situ hybridization.

Authors:  Shilong Xiong; Qian Wang; Lei Zheng; Feng Gao; Junling Li
Journal:  Med Oncol       Date:  2010-11-05       Impact factor: 3.064

2.  EphA2 silencing in nasopharyngeal carcinoma leads to decreased proliferation, invasion and increased sensitization to paclitaxel.

Authors:  Pingqing Tan; Yong Liu; Changyun Yu; Zhongwu Su; Guo Li; Xiaojuan Zhou; Donghai Huang; Xin Zhang; Yuanzheng Qiu; Yongquan Tian
Journal:  Oncol Lett       Date:  2012-06-08       Impact factor: 2.967

3.  Nasopharyngeal Carcinoma: A 15 Year Study with Respect to Clinicodemography and Survival Analysis.

Authors:  Shaqul Qamar Wani; Talib Khan; Saiful Yamin Wani; Liza Rafiq Mir; Mohammad Maqbool Lone; Tariq Rasool Malik; Arshad Manzoor Najmi; Fir Afroz; Mohammad Ashraf Teli; Nazir Ahmad Khan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2016-09-19

4.  Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma.

Authors:  Wenling Zhang; Chen Huang; Zhaojian Gong; Yanhua Zhao; Ke Tang; Xiaoling Li; Songqing Fan; Lei Shi; Xiayu Li; Pan Zhang; Yanhong Zhou; Donghai Huang; Fang Liang; Xinli Zhang; Minghua Wu; Li Cao; Jieru Wang; Yong Li; Wei Xiong; Zhaoyang Zeng; Guiyuan Li
Journal:  J Mol Histol       Date:  2013-03-26       Impact factor: 2.611

5.  Clinical manifestations of aural fullness.

Authors:  Moon Suh Park; Ho Yun Lee; Ho Min Kang; Eun Woong Ryu; Sun Kyu Lee; Seung Geun Yeo
Journal:  Yonsei Med J       Date:  2012-09       Impact factor: 2.759

Review 6.  The prevalence and prevention of nasopharyngeal carcinoma in China.

Authors:  Su-Mei Cao; Malcolm J Simons; Chao-Nan Qian
Journal:  Chin J Cancer       Date:  2011-02

7.  Prognostic implications of dynamic serum lactate dehydrogenase assessments in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.

Authors:  Guan-Qun Zhou; Xian-Yue Ren; Yan-Ping Mao; Lei Chen; Ying Sun; Li-Zhi Liu; Li Li; Ai-Hua Lin; Hai-Qiang Mai; Jun Ma
Journal:  Sci Rep       Date:  2016-03-01       Impact factor: 4.379

8.  Comparison of Dosimetric Benefits of Three Precise Radiotherapy Techniques in Nasopharyngeal Carcinoma Patients Using a Priority-Classified Plan Optimization Model.

Authors:  Qiaoli Wang; Jiyong Qin; Ruixue Cao; Tianrui Xu; Jiawen Yan; Sijin Zhu; Jiang Wu; Guoqiang Xu; Lixiu Zhu; Wei Jiang; Wenhui Li; Wei Xiong
Journal:  Front Oncol       Date:  2021-09-27       Impact factor: 6.244

9.  Long Noncoding RNA Expression Signatures of Metastatic Nasopharyngeal Carcinoma and Their Prognostic Value.

Authors:  Wei Zhang; Lin Wang; Fang Zheng; Ruhai Zou; Changqing Xie; Qiannan Guo; Qian Hu; Jianing Chen; Xing Yang; Herui Yao; Erwei Song; Yanqun Xiang
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.